Sponsors (5)
The bill makes it easier for the U.S. to collaborate with CERN and support international scientific work by extending immunities and streamlining relationships, at the cost of reducing some legal remedies and oversight and giving the President broad discretion over terms.
U.S. and international scientists and researchers would get clearer legal protections and operational ease when collaborating with CERN, reducing legal uncertainty and smoothing participation in joint research projects.
Federal agencies and the President would gain a clear statutory tool to streamline U.S. participation and funding relationships with CERN, making it easier for federally funded programs to coordinate and support international research.
U.S. agencies, universities, and state partners would find it easier to host or transfer equipment and personnel with CERN because of reduced diplomatic or immunities hurdles, supporting scientific infrastructure and collaboration.
Americans (employees, contractors, or claimants) harmed in actions involving CERN or its staff could face reduced legal recourse because extending immunities limits jurisdiction or enforcement options.
State governments and institutions interacting with CERN could face inconsistent protections and unpredictability because the President has broad discretion to set terms and conditions.
Taxpayers and state governments could experience minor fiscal costs or reduced tax, customs, or regulatory oversight in certain transactions involving CERN if IOIA-like benefits apply.
Based on analysis of 2 sections of legislative text.
Authorizes the President to extend International Organizations Immunities Act privileges, exemptions, and immunities to CERN on presidentially determined terms.
Official title: To amend the International Organizations Immunities Act to extend certain privileges and immunities to the European Organization for Nuclear Research.
Introduced July 10, 2025 by Joaquin Castro · Last progress July 10, 2025
Authorizes the President to extend the privileges, exemptions, and immunities available under the International Organizations Immunities Act to the European Organization for Nuclear Research (CERN) on terms the President decides. This creates an explicit statutory basis for designating CERN to receive the same legal immunities that other public international organizations receive when the United States participates by treaty or statute. The change affects legal status and protections (such as immunity from suit and certain tax and customs exemptions) for CERN and its personnel operating in the United States, and it clarifies executive authority to make that designation without requiring additional congressional appropriation language.